Clinical Trials Browser

Phase 1 × Interventional × G250 monoclonal antibody × Clear all

NCT00520533 2022-10-12

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Phase 1 Terminated

8 enrolled 18 charts

Carcinoma, Renal Cell, Mycobacterium Infections, Nontuberculous